Colorectal Cancer

Karcinom debelog crijeva jedan je od vodećih zdravstvenih problema u svijetu, osobito u visokorazvijenim zemljama. U našoj zemlji zauzima po učestalosti drugo mjesto među zloćudnim bolestima, u muškaraca iza raka pluća, a u žena iza raka dojke. Prema posljednjim podacima Republičkog registra za rak 1998. godine u Hrvatskoj je ukupno oboljelo 2.238 osoba (1.227 muškaraca i 1.011 žena). Učestalost bolesti se udvostručuje svakih deset godina nakon 40. godine života. Liječenje karcinoma debelog crijeva je multidisciplinarno, što znači da se u velikog broja bolesnika primjenjuju dva ili tri oblika liječenja, odnosno najčešće nakon kirurškog liječenja još i kemoterapija ili kombinacija kemoterapije i zračenjaColorectal cancer is one of the leading health problems in the world, particularly in the highly developed countries. In our country it is on the second place among malignant diseases, in men after lung carcinoma, and in women after breast carcinoma. According to the latest data of the Republic Register of Cancer for the year 1998, in Croatia was a total number of 2238 patients (1227 men and 1011 women). The incidence of the disease is doubling every ten years after the age of forty. The treatment of the colorectal cancer is multidisciplinary, meaning that in a large number of patients two or three ways of treatment are being applied, i.e. most frequently after surgical treatment follows chemotherapy or a combination of chemotherapy and radiation